Supplementary Figure S3 from Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor–Resistant Head and Neck Squamous Cell Carcinoma
Year: 2026
Type: supplementary-materials
Abstract: Cell cycle profiles of Fadu parental and AfaR cell models after 1, 3, or 5 days treatment with VIC-1911
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7202371041
Cites:
Cited by:
Related to: